These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 763120)

  • 21. [Effect of acetylsalicylic acid on thrombocyte function in patients with diabetes mellitus (review of the literature)].
    Gendeleka GF; Gruzina EA
    Vrach Delo; 1987 Jan; (1):100-5. PubMed ID: 3564399
    [No Abstract]   [Full Text] [Related]  

  • 22. Proceedings: A clinical trial of antiplatelet therapy in patients with coronary arterial disease.
    Michaels L; Galbraith PA; Ledwich JR
    Thromb Diath Haemorrh; 1975 Nov; 34(2):598-9. PubMed ID: 1105881
    [No Abstract]   [Full Text] [Related]  

  • 23. Inhibition of experimental arterial thrombosis in dogs with platelet-deaggregating agents.
    Danese CA; Haimov M
    Surgery; 1971 Dec; 70(6):927-34. PubMed ID: 5124672
    [No Abstract]   [Full Text] [Related]  

  • 24. Platelets and coronary heart disease: therapy update.
    Mehta JL
    Geriatrics; 1982 May; 37(5):129-34, 139. PubMed ID: 7040169
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of prostaglandin-mediated platelet-suppressant drugs on acute cardiovascular catastrophes.
    Sherry S
    Adv Prostaglandin Thromboxane Leukot Res; 1982; 10():173-210. PubMed ID: 6216782
    [No Abstract]   [Full Text] [Related]  

  • 26. Role of platelet-active drugs in coronary artery disease.
    Sherry S
    Cardiovasc Clin; 1983; 14(1):173-89. PubMed ID: 6352025
    [No Abstract]   [Full Text] [Related]  

  • 27. [Prophylaxis and therapy of shunt thrombosis in terminal renal insufficiency (author's transl)].
    Köhler H
    Klin Wochenschr; 1977 Jan; 55(2):49-56. PubMed ID: 834017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mode of action of currently used antiplatelet drugs.
    de Gaetano G; Bertele' V; Cerletti C
    Agents Actions Suppl; 1986; 20():191-201. PubMed ID: 3101442
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effect of sulfinpyrazone on the platelet function and in experimental thrombosis].
    Haas S; Ketterl R; Blümel G
    Fortschr Med; 1981 Jan; 99(4):113-8. PubMed ID: 7274948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiplatelet agents: rationale and results.
    Kelton JG
    Clin Haematol; 1983 Feb; 12(1):311-54. PubMed ID: 6132693
    [No Abstract]   [Full Text] [Related]  

  • 31. [Antiplatelet therapy of thrombosis].
    Maekawa T
    Nihon Rinsho; 1986 May; 44(5):1094-103. PubMed ID: 3528569
    [No Abstract]   [Full Text] [Related]  

  • 32. Critical evaluation of platelet-inhibiting drugs in thrombotic disease.
    Harker LA; Hirsh J; Gent M; Genton E
    Prog Hematol; 1975; 9():229-54. PubMed ID: 766074
    [No Abstract]   [Full Text] [Related]  

  • 33. A sensitive model of venous thrombosis in rats.
    Hladovec J
    Thromb Res; 1986 Sep; 43(5):539-44. PubMed ID: 2944243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The current status of platelet suppressive drugs in the treatment of thrombosis.
    Hirsh J; Gent M; Genton E
    Thromb Diath Haemorrh; 1975 Jun; 33(3):406-16. PubMed ID: 1098213
    [No Abstract]   [Full Text] [Related]  

  • 35. Cerebrovascular disease.
    Warlow CP
    Clin Haematol; 1981 Jun; 10(2):631-51. PubMed ID: 7032789
    [No Abstract]   [Full Text] [Related]  

  • 36. [Spontaneous thrombocyte aggregation in patients with ischemic cardiopathy. Effect of anti-aggregant treatment on thrombocyte function and other coagulation factors].
    Niţă I; Papilian M; Theodorini S; Stroescu V
    Med Interne; 1984; 22(2):113-22. PubMed ID: 6740182
    [No Abstract]   [Full Text] [Related]  

  • 37. [Blood platelets and myocardial infarction].
    Musiał J; Dworski R; Szczeklik A
    Pol Tyg Lek; 1984 Dec; 39(50):1665-8. PubMed ID: 6396594
    [No Abstract]   [Full Text] [Related]  

  • 38. Platelet-active drugs in the secondary prevention of cardiovascular events: an overview.
    Weiss HJ
    Circulation; 1980 Dec; 62(6 Pt 2):V41-3. PubMed ID: 7002351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The pharmacology of sulfinpyrazone (Anturan)].
    Rüegg M
    Wien Med Wochenschr Suppl; 1980; 61():3-8. PubMed ID: 6930768
    [No Abstract]   [Full Text] [Related]  

  • 40. Aspirin: how does it prevent thrombosis?
    Weiss HJ
    J Lab Clin Med; 1992 Jun; 119(6):594-5. PubMed ID: 1593208
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.